Friday, November 14, 2008
Suing a researcher over a bad review is not the way to handle bad news, especially not in the medical marketplace. This one should be classified under "What are they thinking?" Yes, their product is at risk because of the researcher's meta-analysis, but the answer to that is to do their own study to check the researcher's results. The lawsuit is not only bad PR for the company, it is wrong-headed. Perhaps the company doesn't deserve to survive.